Shopping Cart

Appendix 4D and Half Year Results H1 2020

Appendix 4D and Half Year Results H1 2020

Imagion Biosystems has announced Appendix 4D and Half Year Results H1 2020. These are the highlights:

  • Significant advancements towards initiating first-in-human study, on track to commence in

    Q4

  • Balance sheet strengthened by $2.5 million through an oversubscribed Rights Issue and

    shortfall placement

  • $2.2 million R&D tax rebate received for 2019 fiscal year
  • Subsequent to close of H1 $5 million in proceeds received from oversubscribed placement

    in July and $1.29 million received from options exercised

  • Pro forma cash position improved to $10.2 million as of 18 August 2020

Read Appendix 4D and Half Year Results H1 2020.

 

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.